Related Experiment Video

Updated: Oct 6, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K

[Experiences from a multidisciplinary cardiogenetic clinic]

Stellan Mörner1, Bo Carlberg2, Annika Rydberg3

  • 1docent, överläkare, Centrum för kardiovaskulär genetik, Hjärtcentrum, Norrlands universitetssjukhus, Umeå.

Lakartidningen
|January 19, 2022
PubMed

Insights

A specialized center integrates multidisciplinary expertise for monogenic cardiovascular diseases, improving family care through coordinated genetic assessment and cascade screening. This model enhances patient outcomes and genetic counseling accessibility.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Management

Background:

  • Monogenic cardiovascular diseases necessitate integrated genetic and clinical expertise for comprehensive family care.
  • Coordinating genetic assessment, cascade screening, risk estimation, and treatment presents significant challenges.
  • A dedicated center was established to centralize and enhance care for families affected by these conditions.

Purpose of the Study:

  • To report on the experiences and working routines of a specialized center for monogenic cardiovascular diseases.
  • To demonstrate the effectiveness of a multidisciplinary approach in managing these complex genetic conditions.
  • To highlight the benefits of integrated care models for affected families.

Main Methods:

  • Establishment of a center integrating clinical geneticists, cardiologists, angiologists, pediatric cardiologists, and genetic counselors.
  • Implementation of family outpatient clinics for probands and at-risk relatives.
  • Utilization of video conferencing for remote participation of geographically dispersed family members.

Main Results:

  • The center has provided care for over 300 families, encompassing more than 2000 individuals.
  • A seamless organizational structure facilitates collaboration among different medical specialties.
  • Family outpatient clinics and teleconferencing have improved accessibility and engagement.

Conclusions:

  • A multidisciplinary center is effective in providing comprehensive genetic and clinical care for monogenic cardiovascular diseases.
  • Integrated care models, including family-focused clinics and remote consultations, significantly improve patient management.
  • The reported experiences demonstrate a successful framework for managing hereditary cardiovascular conditions.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.8K
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

11.8K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
59
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
84
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
59
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
68
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
84
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
110